Israel Englander Charles River Laboratories International, Inc. Put Options Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $13.1 Million - $17.1 Million	-63,700 Reduced 75.21%	21,000 $4.34 Million
Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $6.74 Million - $9.05 Million	-33,100 Reduced 28.1%	84,700 $22.9 Million
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $16.9 Million - $24.6 Million	102,900 Added 690.6%	117,800 $27.8 Million
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $753,211 - $862,025	-4,100 Reduced 21.58%	14,900 $3.13 Million
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $2.69 Million - $3.64 Million	14,000 Added 280.0%	19,000 $3.84 Million
Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $2.37 Million - $3 Million	-12,000 Reduced 70.59%	5,000 $1.09 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $1.82 Million - $2.51 Million	10,000 Added 142.86%	17,000 $3.35 Million

732

51.8M

233K

236K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.5B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.